These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30743004)

  • 1. American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults.
    Kallwitz ER; Tayo BO; Kuniholm MH; Cai J; Daviglus M; Cooper RS; Cotler SJ
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2301-2309. PubMed ID: 30743004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos.
    Kallwitz E; Tayo BO; Kuniholm MH; Daviglus M; Zeng D; Isasi CR; Cotler SJ
    Liver Int; 2020 Apr; 40(4):889-893. PubMed ID: 31965669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries.
    Rutledge SM; Soper ER; Ma N; Pejaver V; Friedman SL; Branch AD; Kenny EE; Belbin GM; Abul-Husn NS
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2578-2587.e11. PubMed ID: 36610497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PNPLA3 I148M with Liver Disease Biomarkers in Latinos.
    Roe JD; Garcia LA; Klimentidis YC; Coletta DK
    Hum Hered; 2021; 86(1-4):21-27. PubMed ID: 34749354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.
    Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S
    Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
    Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
    Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
    Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
    Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
    Wagenknecht LE; Palmer ND; Bowden DW; Rotter JI; Norris JM; Ziegler J; Chen YD; Haffner S; Scherzinger A; Langefeld CD
    Liver Int; 2011 Mar; 31(3):412-6. PubMed ID: 21281435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
    Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
    World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
    Cavalcante LN; Porto J; Mazo D; Longatto-Filho A; Stefano JT; Lyra AC; Carrilho FJ; Reis RM; Alves VAF; Sanyal AJ; Oliveira CP
    Ann Hepatol; 2022; 27(6):100728. PubMed ID: 35710086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
    Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M
    Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
    Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
    Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
    PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
    Martínez LA; Larrieta E; Kershenobich D; Torre A
    Ann Hepatol; 2017 November-December,; 16(6):909-915. PubMed ID: 29055919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.
    Liu W; Anstee QM; Wang X; Gawrieh S; Gamazon ER; Athinarayanan S; Liu YL; Darlay R; Cordell HJ; Daly AK; Day CP; Chalasani N
    Aging (Albany NY); 2016 Oct; 9(1):26-40. PubMed ID: 27744419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.